Cargando…
A Historical Review of Brain Drug Delivery
The history of brain drug delivery is reviewed beginning with the first demonstration, in 1914, that a drug for syphilis, salvarsan, did not enter the brain, due to the presence of a blood–brain barrier (BBB). Owing to restricted transport across the BBB, FDA-approved drugs for the CNS have been gen...
Autor principal: | Pardridge, William M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229021/ https://www.ncbi.nlm.nih.gov/pubmed/35745855 http://dx.doi.org/10.3390/pharmaceutics14061283 |
Ejemplares similares
-
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
por: Pardridge, William M.
Publicado: (2020) -
Advanced Blood–Brain Barrier Drug Delivery
por: Pardridge, William M.
Publicado: (2022) -
Physiologically Based Pharmacokinetic Model of Brain Delivery of Plasma Protein Bound Drugs
por: Pardridge, William M.
Publicado: (2023) -
Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier
por: Pardridge, William M.
Publicado: (2023) -
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
por: Pardridge, William M.
Publicado: (2020)